Biggest News Aggregation in the World
📰 Johnp Schmid News

Johnp Schmid News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Johnp Schmid. Real-time updates on events, politics, business and more.

Design Therapeutics, Inc. (NASDAQ:DSGN) Director Purchases $66,605.66 in Stock

Design Therapeutics, Inc. (NASDAQ:DSGN – Get Free Report) Director John P. Schmid purchased 17,809 shares of Design Therapeutics stock in a transaction dated Monday, March 25th. The shares were bought at an average price of $3.74 per share, with a total value of $66,605.66. Following the completion of the acquisition, the director now directly owns […]
United States Johnp Schmid Securities Exchange Commission Group Plc Nisa Investment Advisors Design Therapeutics Inc

John P. Schmid Acquires 9,156 Shares of Design Therapeutics, Inc. (NASDAQ:DSGN) Stock

Design Therapeutics, Inc. (NASDAQ:DSGN – Get Free Report) Director John P. Schmid acquired 9,156 shares of Design Therapeutics stock in a transaction on Friday, March 22nd. The stock was acquired at an average cost of $3.62 per share, for a total transaction of $33,144.72. Following the completion of the purchase, the director now owns 9,156 […]
United States Johnp Schmid Design Therapeutics Company Profile Tower Research Capital Securities Exchange Commission Hermes Inc

Insider Buying: Design Therapeutics, Inc. (NASDAQ:DSGN) Director Purchases 9,156 Shares of Stock

Design Therapeutics, Inc. (NASDAQ:DSGN – Get Free Report) Director John P. Schmid bought 9,156 shares of the company’s stock in a transaction on Friday, March 22nd. The stock was purchased at an average cost of $3.62 per share, with a total value of $33,144.72. Following the completion of the transaction, the director now owns 9,156 […]
United States Johnp Schmid America Corp Design Therapeutics Inc Manufacturers Life Insurance Company Tower Research Capital
Source: wkrb13.com

Design Therapeutics, Inc. (NASDAQ:DSGN) Director John P. Schmid Acquires 17,809 Shares

Design Therapeutics, Inc. (NASDAQ:DSGN – Get Free Report) Director John P. Schmid acquired 17,809 shares of the company’s stock in a transaction that occurred on Monday, March 25th. The stock was purchased at an average price of $3.74 per share, for a total transaction of $66,605.66. Following the purchase, the director now owns 26,965 shares […]
United States Nova Scotia Johnp Schmid Design Therapeutics Company Profile Royal Bank Securities Exchange Commission
Source: wkrb13.com

Design Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying - FTC Solar (NASDAQ:FTCI), Design Therapeutics (NASDAQ:DSGN)

The Dow Jones index closed lower by over 150 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Josephk Schachle Ahmadr Chatila Ocuphire Pharma Niravs Jhaveri Heathera Berger Johnp Schmid

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science